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Abstract
Surgical site infections (SSIs) are among the most preventable infections acquired in the
healthcare setting today. The potential for improved patient care and reduced healthcare
spending by decreasing SSIs could save millions of US healthcare dollars and at the same
time lead to better patient outcomes. The purpose of this systematic review was to
explore whether high concentration oxygen delivered to surgical patients undergoing
intraabdominal surgery decreases SSI. A systematic review was conducted to determine
if high concentration oxygen decreases surgical site infection. Databases were searched,
and inclusion and exclusion criteria were applied to select the articles for this systematic
review. The PRISMA framework was used to guide the review and a total of six studies
were critically analyzed. Two data collection tables were created for each article, one that
illustrated the design of the study and one that illustrated the results. The CASP checklist
was utilized to appraise each article critically. Finally, a cross-study analysis was
conducted to compare the studies. Of the six studies, two were statistically significant
1and showed a decrease in SSI, contradicting earlier findings. Based on all the available
research at this time, the use of high concentration oxygen during the intraoperative phase
to decrease SSI should be followed if patient specifics and facility resources
allow. Further studies will need to focus on standardized protocols specific to each
abdominal surgery.
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Does High Concentration Oxygen Decrease Surgical Site Infections?
Background/Statement of the Problem
According to the Centers for Disease Control (CDC), 16 million surgeries were
performed in the United States during 2011 (2018). Of those patients, 157,000 developed
a surgical site infection (SSI). Surgical site infections are among the most preventable
infections acquired in the healthcare setting today. The time frames of pre-operation,
intra-operation, and post-operation all have specific risk factors that can lead to the
development of an SSI, potentially lengthening hospitalization (CDC). Expenditure for
SSI is estimated at 10,000 - 100,000 dollars for each occurrence and more then 4 billion
dollars total, annually (CDC). This results in burgeoning health care costs, as well as an
increase in morbidity and mortality (Reichman & Greenberg, 2009). The annual number
of surgeries are expected to rise along with a growing US population; therefore,
decreasing the number of SSIs is paramount.
Organizations, such as the Institute for Healthcare Improvement (IHI), have
suggested dynamic initiatives that aim to decrease spending in the healthcare field. The
IHI’s Triple Aim for Populations recommends three areas in healthcare where
improvement is needed. These include the restructuring of health care through integrated
approaches such as the improvement of patient care, improvement of population health,
and reduction in costs per capita (IHI, 2018). The Affordable Care Act (ACA) also has
three improvement objectives: increase the number of insured; improve the quality of
patient care; and reduce the cost of health care (Blumenthal, Abrams, & Nuzum, 2015).
Lastly, the Center for Medicare and Medicaid Services (CMS) incorporated the
Innovation Center to come up with new and innovative ways to decrease health care
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spending through payment initiatives (CMS, 2017). This societal push for cost-effective,
innovative healthcare has led to a 19% decrease in SSI between 2008 and 2013 (CDC,
2018). The potential for better patient care and reduced healthcare spending by reducing
SSIs could save millions of healthcare dollars and lead to better patient outcomes.
The World Health Organization (WHO) and the CDC (Berrios-Torres et al.,
2017) have released guidelines on ways to decrease SSI. One recommended guideline put
forth by the WHO is the use of high concentration oxygen (O2), defined as greater than
80% fraction of inspired oxygen (FiO2 ≥ 80%), perioperatively to reduce the risk of
surgical site infections (2016). Evidence in the surgical literature (Al-Niaimi & Safdar,
2009; Belda, et al., 2005; Greif, Akça, Horn, Kurz & Sessler, 2000) has suggested that
intra-abdominal surgical patients who received high concentration O2 had a lower
incidence of SSI post-operatively. There is, however, opposing literature (Gottrup, 2004;
Pryor, Iii, Lien, & Goldstein, 2004) which indicated that similar surgical patients who
received high concentration O2 had a higher risk of SSI.
The WHO’s recommendation comes from years of evaluating evidence-based
research and is a guideline to help aid clinicians all over the world in their practice. But
does the WHO’s suggested guideline related to use of high concentration O2 to decrease
SSI come at an increased risk of patient harm from O2 toxicity? The juxtaposing
outcomes of clinical studies suggest that additional research that examines high
concentration O2 use in the perioperative phase is needed in order for clinicians to make
best evidence-based decisions.
The purpose of this systematic review was to explore whether high concentration
oxygen delivered to surgical patients undergoing intraabdominal surgery decreases SSI.
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According to Polit and Beck (2017), most evidence-based practice guidelines use the
acronym PICO (patient intervention comparison outcome) to help develop a research
question. Using the PICO format, this systematic review attempted to answer the
question: Does the delivery of high concentration oxygen to surgical patients
perioperatively effect the incidence of SSI compared to surgical patients that receive
normal concentration oxygen perioperatively?
Next, a review of the current literature will be presented.
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Literature Review
A comprehensive literature search was accomplished using electronic
bibliographic databases CINHAL, PUBMED, Cochrane, Up to Date, and Google
Scholar. The search utilized the keywords: “SSI”, “oxygen”, “high concentration
oxygen”, “perioperative”, “anesthesia”, “oxygen free radical”, “oxygen toxicity”, and
“hyperoxia”. This literature review also utilized anesthesia textbooks and published
guidelines.
Surgical Site Infections
The CDC defines SSI as an infection occurring at the incision site, or space the
surgery occupied, that occurs within 90 days of surgery (CDC, 2018). Reichman and
Greenberg (2009) published a review on reducing SSI and noted that SSIs lead to an
increase in morbidity and mortality. They explained the most common infections
originate from bacterial, viral, or fungal sources. Hospitalized patients are often exposed
to a multitude of such infectious agents, and when these patients develop an infection, it
is termed a nosocomial infection. While there are many types of infections, and many
sources of infections, only nosocomial SSI are addressed in this review. Providers,
equipment, or even a patient’s natural skin flora can potentially be the source of a
nosocomial SSI. Surgical site infections account for 15-30% of all nosocomial infections,
are the most common infection related to surgery, and lead to increased length of hospital
stay and higher rates of hospital readmissions (Reichman & Greenberg). The authors
estimated that SSI increases the length of stay at a hospital by 9.7 days, with an average
cost of $20,842 per admission and a yearly total of $900 million in healthcare. Hospital
readmissions due to SSIs are estimated to cost upwards of $700 million a year. Both of
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these factors accelerate health care costs while placing the patient at a higher risk for poor
outcomes (Reichman & Greenburg).
According to the 2018 CDC guidelines regarding SSI prevention, an intraabdominal SSI must meet the following criteria: the infection must be within 30-90 days
of the surgery and involve any part of the intra-abdominal area that was opened and
manipulated during the surgery. It must contain at least one of the following: purulent
drainage from a drain in the intra-abdominal region; an organism identified from fluid to
be infectious; or an abscess in the intra-abdominal region. Surgical site infections are the
number one healthcare-associated infection (HAI), reported to be as high as 31% of all
hospitalized infections. They are associated with a 3% increase in mortality; of all the SSI
deaths reported 75% of them are directly due to the infection (CDC).
Nearly half of all SSIs in the US can be prevented, which could help lower the
burden of unnecessary national healthcare spending (Berrios-Torres et al., 2017). The
United States has one of the only health care systems in the world that is built upon a free
market design and also one of the most expensive health care systems of any nation. All
the different sections of the US healthcare system are attempting to make a profit,
partially explaining why health care costs are so incredibly high in the US. Insurance
companies have recently started to decline payments for SSI and the extra care associated
with SSI. Preventable infections now receive much attention because hospital
reimbursement rates for nosocomial infections have either decreased or become
nonexistent. Surgical site infections cost an average of $10,433 per infection and could
exceed $90,000 when a prosthetic is involved (Berrios-Torres et al.). It is in the best
interest of any health care facility to implement the most efficient practices to reduce SSI.
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Surgical Site Infection Risk Factors
Barie and Eachempati (2005) presented a state of science publication on SSI and
risk factors, which described a surgical incision as ischemic, injured tissue susceptible to
infection. The authors used the National Nosocomial Infections Surveillance System
(NNIS) to list the most common risk factors for SSI. These factors are separated into
three categories: patient factors; environmental factors; and treatment factors. Patient
factors are any physical condition that lowers a patient’s ability to fight off an infection
and are listed as ascites, chronic inflammation, corticosteroid therapy (controversial),
obesity, diabetes, extremes of age, hypocholesterolemia, hypoxemia, peripheral vascular
disease (especially for lower extremity surgery), postoperative anemia, prior site
irradiation, recent operation, remote infection, skin carriage of staphylococci, skin disease
in the area of infection (eg, psoriasis), and undernutrition (Barie & Eachempati).
Environment factors are any risk from the external world and are listed as contaminated
medications, inadequate disinfection/sterilization, inadequate skin antisepsis, and
inadequate ventilation (Barie & Eachempati). Treatment factors are any risk involved
with the actual surgery and are listed as an emergency procedure, hypothermia,
inadequate antibiotic prophylaxis, oxygenation (controversial), prolonged preoperative
hospitalization, and prolonged operative time (Barie & Eachempati). Barie and
Eachempati stated that with strict adherence to the established guidelines, SSIs can be
reduced by as much as 27% (2005).
Critical Practice Guidelines: Overview
Evidence-based clinical practice guidelines are an attempt to review large bodies
of evidence and convert the evidence into manageable clinical guidelines for practice
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(Polit & Beck, 2017). Evidence-based clinical guidelines have four features. First, they
are usually based on systematic reviews, and they give some form of a recommendation
for a decision-making process. Second, they attempt to balance benefit with risk. Third,
they are developed to guide clinical practice. Fourth they are typically developed by a
group made up of researchers, clinicians, and experts (Polit & Beck).
Guidelines are available for a variety of clinical decisions. Typically, guidelines
“define a minimum set of services and actions appropriate for certain clinical conditions”
(Polit & Beck. 2017, p. 28). Most guidelines are developed by an organization such as the
WHO or the CDC who have sponsored the research of these clinical conditions, and most
will post their guidelines on their website (Polit & Beck). There is no one central
guideline hub to find the most current guidelines, but Polit and Beck recommend the
National Clearinghouse (www.guideline.gov) for nursing and healthcare guidelines in the
United States. With the increasing amounts of clinical guidelines being released, there is
a greater chance of multiple guidelines which can lead to conflicting recommendations
(Polit & Beck). When there are multiple guidelines, Polit and Beck recommend to
critically appraise each organization’s recommendation and choose the one with the
“strongest and the most-up-to-date evidence” (p. 29) that best fits with one’s clinical
practice.
The WHO guidelines. The WHO sponsored and released guidelines on
decreasing SSI (2016). The objectives were to provide comprehensive evidence, and
expert-based recommendations and to support health care settings and clinicians develop
infection prevention programs. The prevention of SSI is a WHO global priority in patient
safety. The WHO panel of international experts came together with relevant evidence to
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develop a global set of guidelines that could be followed by any institution worldwide.
The WHO developed SSI guidelines specifically to increase awareness of the “global
burden” associated with SSI in the healthcare settings and mobilize the anesthetist who
provides direct patient care (2016).
The WHO (2016) expert panel based their recommendation on 11 randomized
control trials (RCT) that compared the administration of high versus low concentration
oxygen, in the perioperative phase, in the adult population with an endotracheal tube that
could measure and deliver a set amount of oxygen. Using evidence-based and expertbased recommendations, the WHO created a guideline of preventive measures to
decrease SSI in the perioperative phase. These global guidelines take into account the
balance between benefit and harm, cost and resource implications, and patient values and
preference across the world (WHO). The WHO guideline noted that SSIs are a significant
cost burden to the world and especially the low and middle-income countries. The WHO
recommended 16 ways to decrease the incidence of SSI. The first recommendation notes
that the adult patients undergoing general anesthesia with endotracheal intubation for
surgical procedures should receive 80% FiO2 intraoperatively. If feasible, this should be
initiated in the immediate preoperative period and continued into the postoperative period
for two to six hours. As this recommendation is central to the purpose of this paper, it
will be examined in detail in this systematic review.
The WHO “strong guideline recommendations” to reduce SSI include patients
with known nasal carriage of S. aureus should receive intranasal applications of
mupirocin 2% ointment with or without a combination of chlorhexidine gluconate body
wash. It is recommended that mechanical bowel preparation alone (without the
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administration of oral antibiotics) should not be used in adult patients undergoing elective
colorectal surgery. In patients undergoing any surgical procedure, hair should not be
removed or, if absolutely necessary, should only be removed with a clipper. Shaving is
strongly discouraged at all times, whether preoperatively or in the operating room.
Surgical antibiotic prophylaxis (SAP) should be administered before surgical incision,
when indicated. Surgical antibiotic prophylaxis should be administered within 120 min
before incision, while considering the half-life of the antibiotic. Surgical hand preparation
should be performed either by scrubbing with a suitable antimicrobial soap and water or
using a suitable alcohol-based hand rub before donning sterile gloves. Alcohol-based
antiseptic solutions based on CHG for surgical site skin preparation should be used in
patients undergoing surgical procedures. Surgical antibiotic prophylaxis administration
should not be prolonged after completion of the operation (WHO).
Other Guidelines for Reducing SSIs. The CDC used research conducted by
Berrios-Torres et al. (2017) as the foundation for their guidelines on SSI. Berríos-Torres
et al. undertook a targeted systematic review of the literature to find clinically relevant
studies that were current and involved the theme of SSI. In the initial search, the authors
found 5,759 studies that met the criteria for inclusion. Using the Grading of
Recommendations, Assessment, Development, and Evaluation (GRADE) critical
appraisal tool, they refined their full-text review studies to 896. In addition, they hired
two independent reviewers to appraise the 896 studies, and from that pool of studies, they
selected 170 to be included in the review. They narrowed their research to five studies
that specifically examined the effects of supplemental high concentration oxygenation
during the perioperative phase of intraabdominal surgery.
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When Berrios-Torres et al. (2017) narrowed their search to three studies specific
to elective colorectal surgery and the effects of supplemental high concentration
oxygenation during the perioperative phase, they found no significant (p = 0.07) benefit
to the use of high concentration O2 (FiO2 > 80%) during surgery. They attributed the any
significant decrease in SSI that the authors of the studies may have had, to the addition of
other protocols used in the perioperative phase such as maintaining normothermia and
generous fluid replacement. They suggested that a multitude of therapies used together
can decrease SSI, including parenteral antimicrobial prophylaxis, non-parenteral
antimicrobial prophylaxis, glycemic control, normothermia, oxygen, antiseptic
prophylaxis, and biofilm (Berrios-Torres et al.).
Most of these recommendations have already been put in place and are viewed
less as guidelines and more as standards of care for the operative phase. Berrios-Torres et
al. (2017) stated that when therapies are combined, they can have a synergistic effect.
The notion to combine therapies is similar to the recommendation by Aga et al. (2015) to
account for all risk factors before surgery and use a multimodal approach to decrease the
incidence of SSI.
Abdominal Surgical Site Infection Risk Factors.
Abdominal SSIs, in particular, have been shown to occur in up to 17.4 % of intraabdominal surgeries (Razavi, Ibrhimpoor, Kashani & Jafarian, 2005). Kalakouti et al.
(2018) reported that abdominal SSI can range from 3% to 30%, and up to 40%, without
proper antibiotics. Abdominal surgery is especially prone to surgical wound infections
due to the nature of visceral handling intra-operatively and dissemination of
microorganisms from the bowel (Kalakouti et al.).
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In a prospective cohort study conducted by Aga et al. (2015), researchers looked
at the incidence and risk factors of SSI after abdominal surgery that lead to increased
health care spending, along with morbidity and mortality. In their study of 302 patients
who had intraabdominal surgery between 2005-2007, the total SSI rate was 22.2%. Aga
et al. estimated that for every SSI, at least six additional days of hospitalization are
required, and each day significantly increases spending on health care. The increased risk
can be related to the fact that the abdominal cavity and intestines have higher
concentrations of bacteria than the rest of the body. Numerous patient-specific risk
factors were identified, including advanced age, malnutrition, diabetes mellitus, smoking,
morbid obesity, and an impaired immune system. A univariate analysis of intraabdominal surgeries demonstrated additional risk factors for SSI including increased
length of hospital stay, an ASA score greater then 2, long duration of surgery, quality of
patients’ skin preparation, preoperative hair removal, prophylactic antibiotic, operating
room ventilation, sterilization of surgical equipment, presence of a surgical drains, and
surgical technique. While an increased stay can be related to an SSI, it was also identified
by Aga et al. as a risk factor for those very infections.
Oxygen and Surgery
Oxygen is the third most abundant element in the universe and is the most vital
for life (Hall, 2014). The body uses O2 as a fuel in cellular respiration to produce the
energy needed for life. For O2 to reach the lungs, it needs to travel through the airway.
The airway is made up of the nasal and oral pharynx, upper pharynx, lower pharynx,
trachea, bronchi, bronchioles, alveolar sacs, and finally the individual alveoli where O2
diffuses across the cell membrane and is absorbed into the blood (Hall, 2014). Once O2
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has diffused in the blood, it can travel to where the body needs it most (Hall). During
intra-abdominal surgery, the oxygen-rich blood can travel into the intra-abdominal
compartment to promote wound healing.
Oxygen can be a liquid, solid, or a gas depending on the atmospheric pressure and
temperature. Oxygen under normal conditions is a gas. The air that surrounds earth the
same air we breathe is made up of 20.95 percent O2 commonly rounded up to 21%.
Oxygen makes up only a partial pressure of the total pressure in the atmosphere since
there are other gasses, mainly nitrogen (Hall, 2014; Nagelhout & Plaus 2014). Dalton’s
Law that states the total pressure expressed as P, is made up of all the elements in the air,
(nitrogen, oxygen, argon) this can also be said as the partial pressures of nitrogen = Pn,
Oxygen = Po, and Argon = Pa together. The equation can be expressed as P = Pn + Po +
Pa (Hall, 2014).
An essential aspect of a patient when under an anesthetist’s care is their airway.
The airway delivers O2 to the lungs in exchange for carbon dioxide. During the
perioperative phase, the anesthetist is in control of the airway and the amount of O2 a
patient receives. Typically, a patient that undergoes surgery with general anesthesia will
first be intubated with an endotracheal tube (ETT) to secure and protect a patient’s airway
(Nagelhout & Plaus, 2014). The ETT is connected to a mechanical ventilator that is part
of the anesthesia machine.
The anesthesia machine is a fundamental piece of equipment to the anesthetist,
and on the most basic level, it is used to control a patient’s ventilation and O2 delivery
(Butterworth, Mackey, Wasnick, Morgan, & Mikhail, 2013). Anesthesia machines in the
US must adhere to standards promulgated by the American Society for Testing and
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Materials F1850 (ASTM F1850). One such standard is that every anesthesia machine
must have a continuous pipeline supply O2 and a spare tank of O2 behind the machine in
case of pipeline failure. This standard sadly is not a global standard and many
undeveloped countries have minimal resources, and a tank of O2 may be hard to obtain.
From the anesthesia machine, the percentage of O2 can be adjusted with a turn of a dial.
The anesthetist can adjust the fraction of inspired oxygen (FiO2) in the lungs from 21%
FiO2 (low concentration O2, also referred to as room air) to 85% FiO2 (high
concentration O2) (2014). The correct amount of O2 administered to a patient has many
co-factors such as the length of the procedure, the patients co-existing diseases, and the
patients baseline arterial oxygen saturation (SpO2) to name a few. The American Society
of Anesthesiologists (ASA) standards do not indicate the amount of O2 a patient receives
during surgery (2015). During a short procedure, an anesthetist may administer 100%
FiO2 for the entire procedure with the thought that it is better to have the patient
maximally oxygenated.
Clinicians can continuously monitor oxygenation in a patient using pulse
oximetry. The ASA standards for basic monitoring during delivery of anesthetics
includes “a quantitative method of assessing oxygenation” such as pulse oximetry (2015).
The pulse oximeter should include a pitch pulse tone that is variable, meaning a low pitch
sound is heard with low saturated O2 levels, and a high pitch sound is heard with highsaturated O2 levels, and should alarm with a low saturated O2 (ASA). The SpO2 can be
used to estimate of the amount of O2 in the blood. Every anesthesia machine has a
monitor that displays the SpO2. During induction and intubation, the anesthetist is
looking directly at the patient and the airway and is unable to focus on the monitor. The
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variable pitch pulse tone assigned to the SpO2 provides the anesthetist the ability to
monitor SpO2 and heart rate audibly while visually looking directly at a patient
throughout the case (Nagelhout & Plaus 2014).
Preoxygenation. During elective surgery the anesthesia provider has the ability to
provide adequate preoxygenation by administering 100% O2 for 3 minutes (Pandey,
Ursekar, & Aphale, 2014). Effective preoxygenation with 100% O2 eliminates nitrogen
from the lungs and replaces it with O2 (Nagelhout & Plaus, 2014). The increase in PaO2
allows the anesthetist time to secure the airway after the induction of anesthesia, when a
patient is no longer breathing and thereby avoid hypoxia.
To avoid hypoxia and its deleterious effects during the induction of anesthesia,
preoxygenation is crucial (Pandey et al., 2014). However, there are numerous ways to
preoxygenate a patient. Pandey et al. conducted an RCT examining two popular methods
used for preoxygenation to determine if preoxygenation was best achieved by
administration of 100% O2 for three minutes with normal respiratory tidal volumes prior
to induction versus four maximal inspirations with 100% O2The study examined 100
surgical patients and the time it took for an apneic patient’s SpO2 to decrease to 90%.
Study results were statistically significant (P < 0.05) and found that the mean time
to desaturation in four maximal breaths method was 110.40 ± 30.27 seconds. The mean
time to desaturation the three minutes method was 281.70 ± 18 seconds. The authors
concluded that the administration of 100% O2 over three minutes with normal tidal
volumes prior to induction of anesthesia is an effective and safe method of
preoxygenation (Pandey et al., 2014).
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Hypoxia. Hypoxia is defined as a SpO2 of less than 90%, or a PO2 of less than 60
mmHg (Hall, 2016). When looking at the oxygen disassociation curve (Figure 1)
provided by Creative Commons Attribution-Non-Commercial-Share Alike 3.0 License, a
SpO2 of 100% can be correlated with a PO2 of 100 milligrams of mercury (mmHg).
However, a slight decrease in SpO2 can be a significant decrease in PO2. If SpO2 is
decreased by 10% to a SpO2 of 90% the correlated PO2 decreases to 60 mmHg, which is
a 40% decrease in the total amount of O2.

Figure 1. Oxygen disassociation curve
Hypoxia is a lack of oxygen. According to Hall (2016), there are five types of
hypoxia. There is inadequate oxygenation of the blood in the lungs because of extrinsic
factors, pulmonary diseases, venous-to-arterial shunts, inadequate O2 transport to the
tissues by the blood, and inadequate tissue capability of using O2 (Hall). Inadequate
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oxygenation of the blood in the lungs because of extrinsic factors is of significant concern
for anesthetists. The extrinsic factors can be subdivided into a deficiency of O2 or
hypoventilation. Both of these extrinsic factors are managed by anesthetists and can be
controlled by the anesthesia machine. If not treated, hypoxia can cause the death of the
cells throughout the entire body including the epidermis (skin layer), intra-abdominal
tissue, and cardiac cells, which can result in cardiac arrest (Hall). Medical professions
learn early in their training to avoid the perils of hypoxia. Even the basic first responder
is taught that oxygenation is crucial to life. The treatment for hypoxia is O2. Hypoxia can
be treated with 100 percent O2, or high concentration O2 therapy, which will deliver five
times as much O2 into the lungs with each breath, compared to a patient breathing room
air (Hall).
Oxygen Toxicity. Oxygen toxicity or hyperoxia is when cells, tissues, and organs
are exposed to an excess supply of O2 or higher than the average partial pressure of O2.
Hyperoxia, or the delivery of high concentration O2 greater than 21% room air, has only
been achievable with modern advances in the medical field of O2 tanks and hyperbaric
chambers. The advancements over the past century have enabled humans to breath
greater than 21% O2. The ability to now provide hyper oxygenation has created a new set
of risk factors stemming from O2 toxicity (Nagelhout & Plaus, 2014).
The pathophysiology behind O2 toxicity is related to an increase in the highly
reactive O2 free radicals that are products of O2 metabolism (Chawla & Lavani. 2011).
An increase in O2 creates an increase in O2 free radicals, and if antioxidants do not
counteract the O2 free radicals in the body, toxicity can occur. Oxygen can be
metabolized into free radicals such as superoxide anion, hydrogen peroxide, and hydroxyl
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radicals when there is an abundance of O2 build up. As metabolites increase in the body
and exert their toxic effects, they cause abnormal functioning of the body (Chawla &
Lavani). The toxic O2 free radicals can act on the cells and organelle membranes and
interfere with cellular functions like enzyme and protein transport and permanently stop
cellular growth (Malhotra, Schwartz, Schwartzstein, Manaker, & Finlay, 2015). Other
than the concentration along with the duration of FiO2, there are other risk factors for O2
toxicity. Advanced age, radiation therapy, and chemotherapy all alter the healthy
development of antioxidants and predispose a person to O2 toxicity (Nagelhout & Plaus,
2014).
Since the very discovery of oxygen, the debate of just how much oxygen is a good
thing was started and continues today. Joseph Priestly is the scientist credited with the
discovery of oxygen in 1775 (Ford, 2004). Priestly noted that a candle that burned in pure
oxygen burned faster and brighter than a candle that burned in room air. Priestly
hypothesized at the time of discovery that too much oxygen might also be toxic and
accelerate the lifespan of man. Priestly’s hypotheses started the debate about how much
oxygen do we actually need (Ford).
With technological advances, O2 can now be concentrated and stored in tanks and
delivered in higher than atmospheric concentrations to a patient undergoing surgery. A
high concentration of O2 delivered to a patient can have adverse effects. Nagelhout and
Plaus (2014) detail in their textbook that the prolonged (greater than 24 hours) use of
high concentration O2, defined as 50 percent FiO2, is potentially toxic and can result in
permanent and irreversible damage to the lungs. Also, “deleterious effects” can result
from shorter periods of time, even under 24 hours (p.648). The amount of lung damage
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can be directly correlated to higher concentrations of FiO2 and a longer duration of
exposure to the higher concentration FiO2 (Nagelhout & Plaus).
Physical symptoms related to high concentration O2 and its toxic effects develop
in as early as six hours. The early signs and symptoms related to high concentration O2
exposure include substernal chest pain that is felt more with inspiration, tachypnea, and a
non-productive cough (Nagelhout & Plaus, 2014). Signs and symptoms that can be seen
within 24 hours of O2 exposure include paresthesia, anorexia, nausea, and headache.
According to Malhotra et al., oxygen toxicity is essentially an overdose of oxygen
(2015). Oxygen toxicity / hyperoxia on a biological chemical level is not yet clearly
understood (Malhotra et al.). The leading theory is that an overabundance of O2 in the
body is transformed into free radicals and other toxic substances. Oxygen greater than 21
percent atmospheric pressure (a normal oxygen level) can cause injury (Malhotra et al.).
Clinical consequences of O2 toxicity are known to include cellular injury, absorptive
atelectasis, accentuation of hypercapnia, airway injury, parenchymal injury, potentiation
by bleomycin, extrapulmonary toxicity, and augmentation of antioxidants and
extrapulmonary toxicity. Suggested methods to prevent or reduce injury from O2 toxicity
include prevention of over oxygenation by reducing FiO2 to as low as a patient can
tolerate and using arterial oxygen saturation (SaO2) as a guide to prevent O2 toxicity
(Malhotra et al.).
Oxygen’s Role in Decreasing SSI.
Administration of high concentration O2 has the ability to raise the partial
pressure of oxygen (PaO2) in the body while decreasing the partial pressure of the other
elemental gases (Hall, 2016). When the partial pressure of oxygen is increased in the
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lungs, it diffuses into the blood in higher concentrations (Hall). The higher concentrations
then travel throughout the body. Gottrup (2004) explained that a continuous supply of
O2 rich blood from the lungs to the wound is vital for wound healing, and resistance
from postoperative SSI is only possible when microcirculation of nutrition is able to
reach the tissue. “The main component of the nutrition is O2, which is critically
important for healing a wound by the production of granulation tissue and for ensuring
resistance against infection” (p.312).
Oxygen’s role in decreasing SSI and wound healing continues throughout the
entire wound healing process. Oxygen is continuously needed in the production of energy
during cellular respiration. The energy produced is then used throughout the body. The
cells of the different organs in the body use O2 to heal itself (Smet et al., 2017). A
detailed look at the role of O2 on the microscopic level shows that O2 is responsible for
the synthesis of collagen, proliferation, and defense against infection-causing bacteria.
Oxygen-derived peroxides, such as hydrogen peroxide, are byproducts of O2 reactions in
the body (Smet et al.). These peroxides stimulate reactive oxygen species (ROS), and
they are super-oxides that are bacterio-toxic. The ROS are also potent stimulators of
angiogenesis that form new blood vessels, which in turn can deliver more oxygen-rich
blood and remove waste.
Smet et al. (2017) conducted a systematic review which evaluated 65 studies that
investigated O2 usage in wound healing. Using the Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA) as a guideline, they evaluated and
categorized studies according to the type of O2 therapy. These categories included topical
O2 therapy, oxygen-dressing therapy, hyperbaric O2 therapy, and supplemental inspired
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O2. Smet et al. reviewed six experimental animal studies that used O2 dressing therapy.
They found that O2 dressing therapy in wound healing accelerated wound healing as
evident by faster wound closure, and less inflammation. Also reviewed were three RCTs
that tested topical O2 therapy, which delivers high flow O2 to a wound bed. In the review,
the authors examined venous ulcers over a 12-week period using topical O2 therapy
versus a conventional compression dressing. Smet et al. found that with the use of O2 to a
wound bed, patients had a faster to wound closure time. The proportion of completely
healed ulcers at the 12-week mark with 80% with topical O2 therapy was improved
compared to 35% O2 therapy with a compression dressing.
High Concentration Oxygen
The use of high concentration O2 in surgery to reduce SSI has been an ongoing
area of study. The meta-analysis conducted by the WHO (2016) showed that high
concentration O2 given perioperatively was beneficial in reducing SSI when compared to
low concentration O2. The expert panel noted that this effect was only observed when the
patient was intubated during surgery and delivery and continuous measurement of high
concentration O2 was achievable. The amount of oxygenation to optimize wound healing
without over oxygenating is still being debated and more research is needed.
There is increased confusion regarding the use of oxygenation during surgery
related to differing guidelines released by the CDC (2018) and WHO (2016) for SSI
prevention. The CDC recognizes the use of high concentration O2 during the
perioperative phase as a possible therapy to decrease SSI but states “no recommendation”
as their guidelines. The CDC stated that while there have been studies that show a
reduction in SSI with the use of high concentration O2, the evidence is not conclusive,
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and the risk of high concentration O2 may be more deleterious than any benefit of
receiving high concentration O2 during the perioperative phase (CDC, 2018). The WHO
(2016) published guidelines for use high concentration O2 during the perioperative phase
of intraabdominal surgery to reduce the incidence of SSI. The WHO stated that there is
no significant risk of harm from the use of high concentration O2 and adult patients
undergoing general anesthesia with endotracheal intubation for surgical procedures
should receive 80% fraction of inspired O2 intraoperatively to reduce SSI and, if feasible,
in the immediate postoperative period for 2–6 hours (2016).
Barie and Eachempati (2005) suggested that the use of high concentration O2 may
have an antibacterial effect and its use in the perioperative phase would be beneficial. In
their state of science review of SSI, they examined patients undergoing intraabdominal
surgery who had received high concentration O2 (80% FiO2) perioperative and continued
to receive high concentration O2 for two hours post operation versus low concentration
O2 (30% FiO2) perioperative. When they examined a study of over 500 patients, they
found that those who received the high concentration O2 peri-operatively had a 50%
decrease in SSI (5.2% versus 11.2%). However, a separate study that included 165
patients examined the same criteria and found that the SSI rate doubled (25% versus
11.3%). The authors concluded that the use of perioperative oxygen O2 should be
considered as a treatment factor, but with the caveat that it is still controversial. Barie and
Eachempati also raised the question of inconsistencies and inaccuracy of data on SSI,
especially since not all SSI are reported. It should be noted that currently, a higher
number of surgical procedures are done on an outpatient basis, making these procedures
more difficult to monitor for SSI.
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While evidence from studies on supplemental high concentration oxygenation
during the perioperative phase of intraabdominal surgery looks promising, Berrios-Torres
et al. cautioned that it is inconclusive at this time (2017). The use of O2 is listed in their
guidelines as “no recommendation/unresolved” (p. E4). They stated that a patient with
normal pulmonary function may benefit from receiving high concentration O2
perioperatively to reduce SSI, but it is a tradeoff between the benefit and harm of O2
(2017). The lack of a formal recommendation and suggestion of a tradeoff between
benefit and harm reaffirms that further studies are needed to address the use of high
concentration O2 during the perioperative phase.
Therefore, the purpose of this systematic review was to explore whether high
concentration O2 delivered to surgical patients undergoing intraabdominal surgery
decreases SSI.
Next, the theoretical framework used to guide this project will be presented.
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Theoretical Framework
Two frameworks were used to guide this paper: Pasteur’s Germ Theory and
PRISMA.
Germ Theory
Louis Pasteur’s Germ Theory from 1858 stated that a specific organism or germ is
capable of causing an infectious disease (McEwen & Wills, 2014). The idea that a germ
could cause infection or disease was unique at that time. Before Pasteur’s germ theory,
the leading theory was the theory of miasma. The miasma theory proposed that disease
came from bad air sometimes referred to as night air. This bad air was thought to be a
product of the bad environment. It was thought that the decomposing matter or miasmata
would fill the air and disease would spread. Though the theory of miasma has since been
disproved, it guided Pasteur in his development of the germ theory (Smith, 2012).
Pasteur was studying how to prevent wine from spoiling when he developed the
Germ Theory. According to the miasma theory in use at the time, the air caused the wine
to spoil. Pasteur hypothesized that it was not the air, but instead, a microorganism in the
air that caused the spoiling. Through better scientific instruments, like the microscope,
Pasteur was able to isolate yeast, the organism responsible for fermentation. Pasteur was
also able to detect the growth of microorganisms that he deemed responsible for the
spoiling of wine (Smith, 2012). Pasteur extended his theory to many other types of
mediums in an attempt to replicate his findings. The Germ Theory became accepted, and
other great discoveries, like pasteurization and the concept of sterility, arose from it.
Thanks to the theory of germs, hand washing, sterile gowns, gloves, surgical fields, and
equipment are now the gold standard in surgical operating rooms.
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Pasteur’s Germ Theory is theoretically sound and easy to understand. The
concepts that the theory relies on are common knowledge today. One example of this is
Pasteur’s concept of a microorganism. When Pasteur first theorized about germs, a
microorganism was a radical idea, yet today the microorganism is proven. Germ theory is
not overly complicated and in fact is so simple that even young children can understand
it. One of the first lessons preschool children learn is how to wash their hands before
eating or after using the restroom to get rid of any germs that might be on their hands.
The theory and assumptions that microorganisms can cause infectious disease are
adequately explained and still hold true today. The microscope helped proved the concept
of a microorganism, and through many experiments and studies, one can safely say that
some microorganisms can cause infectious disease. The Germ Theory continues to be an
essential theory and has been shared by many different disciplines, as it has excellent
generalizability. Health care workers, scientists, food service industry workers, and
preschool teachers have embraced the germ theory. The knowledge gained from Germ
Theory helped the profession of nursing tremendously in infectious disease prevention.
The Germ Theory was used to guide a recent study about hand washing. The
researchers wanted to examine the role that hand hygiene of the surgical patient might
play in SSIs. They proposed that by following the principles from the Germ Theory,
effective hand hygiene would decrease or eliminate any organism on the hands and
thereby decrease SSIs caused by the spread of infectious organisms from surgical
patients’ hands. Ardizzone, Smolowitz, Kline, Thom, and Larson (2013) found that the
medical staff believed they offered the opportunity for hand hygiene to patients, but it
was observed that only 14 of 81 patients were provided hand hygiene opportunities
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(17.3%). After an in-service education on the importance of hand hygiene, nursing staff
assisted by offering the patient the opportunity to wash hands in the sink with soap and
water or with an alcohol based hand cleansing solution and they observed an increase of
37 out of 83 opportunities (44.6%). The authors concluded that “efforts to increase hand
hygiene should be directed toward patients as well as healthcare workers” (p.490). Hand
washing and compliance to universal protocols of infection prevention result in lower
incidence of SSI and ultimately saves lives (Ardizonne et al.). The Germ Theory provides
the foundation for understanding bacteria and its transmission.
PRISMA Framework
The framework used to specifically guide this systematic review was the
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
statement (Moher, Liberati, Tetzlaff, & Altman, 2015). The PRISMA-P statement
contains a 17-question checklist (Figure 2, next page) that examines administrative
information, introduction, and methods of a systematic review. PRISMA also contains a
flow diagram that provides a conceptual visualization of how the articles appraised in a
systematic review are selected. The criteria in the PRISMA checklist should be followed
to present a clear and concise systematic review. The PRISMA statement was developed
to help guide authors in reporting the necessities while conducting a systematic review
and can also help appraise a journal article.
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Section and topic

Item No

Checklist item

ADMINISTRATIVE INFORMATION
Title:
Identification

1a

Identify the report as a protocol of a systematic review

Update

1b

If the protocol is for an update of a previous systematic review, identify as such

Registration

2

If registered, provide the name of the registry (such as PROSPERO) and registration number

Authors:
Contact

3a

Provide name, institutional affiliation, e-mail address of all protocol authors; provide physical mailing
address of corresponding author
Describe contributions of protocol authors and identify the guarantor of the review

Contributions
Amendments
Support:
Sources

3b
4

If the protocol represents an amendment of a previously completed or published protocol, identify as
such and list changes; otherwise, state plan for documenting important protocol amendments

5a

Indicate sources of financial or other support for the review

5b
5c

Provide name for the review funder and/or sponsor
Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol

Rationale

6

Describe the rationale for the review in the context of what is already known

Objectives

7

Provide an explicit statement of the question(s) the review will address with reference to participants,
interventions, comparators, and outcomes (PICO)

Eligibility criteria

8

Specify the study characteristics (such as PICO, study design, setting, time frame) and report
characteristics (such as years considered, language, publication status) to be used as criteria for
eligibility for the review

Information sources

9

Describe all intended information sources (such as electronic databases, contact with study authors,
trial registers or other grey literature sources) with planned dates of coverage

Search strategy

10

Present draft of search strategy to be used for at least one electronic database, including planned
limits, such that it could be repeated

Study records:
Data management
Selection process

11a
11b

Describe the mechanism(s) that will be used to manage records and data throughout the review
State the process that will be used for selecting studies (such as two independent reviewers) through
each phase of the review (that is, screening, eligibility and inclusion in meta-analysis)
Describe planned method of extracting data from reports (such as piloting forms, done independently,
in duplicate), any processes for obtaining and confirming data from investigators
List and define all variables for which data will be sought (such as PICO items, funding sources), any preplanned data assumptions and simplifications

Sponsor
Role of sponsor or
funder
INTRODUCTION

METHODS

Data collection
process

11c

Data items

12

Outcomes and
prioritization

13

List and define all outcomes for which data will be sought, including prioritization of main and
additional outcomes, with rationale

Risk of bias in individual
studies

14

Describe anticipated methods for assessing risk of bias of individual studies, including whether this will
be done at the outcome or study level, or both; state how this information will be used in data
synthesis

Data synthesis

15a
15b

15c

Describe criteria under which study data will be quantitatively synthesized
If data are appropriate for quantitative synthesis, describe planned summary measures, methods of
handling data and methods of combining data from studies, including any planned exploration of
consistency (such as I2, Kendall’s τ)
Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression)

15d

If quantitative synthesis is not appropriate, describe the type of summary planned

Meta-bias(es)

16

Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective
reporting within studies)

Confidence in cumulative
evidence

17

Describe how the strength of the body of evidence will be assessed (such as GRADE)

Figure 2. PRISMA-P checklist (Moher et al., 2015)
The methodology guiding this systematic review will be presented next.
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Method
Purpose
The purpose of this systematic review was to determine whether high
concentration O2 delivered to surgical patients undergoing intraabdominal surgery
decreases SSI.
Research Question
Does the delivery of high concentration oxygen to surgical patients
perioperatively effect the incidence of SSI compared to surgical patients that receive
normal concentration oxygen perioperatively?
Design
The design of this paper was a systematic review that aimed to review and
analyze the outcome variable of SSI with the use of high concentration O2 vs. low
concentration O2 perioperatively during intraabdominal surgery.
Search Strategy
A comprehensive literature search was conducted using electronic bibliographic
databases, including CINHAL, PUBMED, Cochrane, and Google Scholar. The search
utilized the keywords: “RCT”, “SSI”, “high concentration oxygen”, “perioperative”,
“anesthesia”. The PRISMA flow diagram (Figure 3, next page) was used to display the
search path and how the articles appraised for this systematic review were selected. The
number of articles diminishes based on identification, screening, eligibility and inclusion.

Identification
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Records identified through

Additional records identified

database searching

through other sources

Screening

Records after duplicates removed

Records excluded

Eligibility

Full-text articles assessed

Included

Records screened

Studies included in

for eligibility

quantitative synthesis

Figure 3. PRISMA Flowchart (Moher et al., 2009)

Full-text articles excluded,
with reasons
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Inclusion/Exclusion Criteria
To meet the inclusion criteria for this systematic review, the sample studies
needed the following criteria: (a) adults 15 year of age or older; (b) patients undergoing
intra-abdominal surgery, (c) patients who received general anesthesia, (d) use of normal
concentration oxygen during intraoperative phase (FiO2 < 35%), (e) use of high
concentration oxygen during the intraoperative phase (FiO2 > 80%), (f) monitoring of
SSI, (g) studies must be an RCT, or control trial. The literature search was limited to fulltext electronic Journal articles written after the year 2000 and written in English, or that
have been translated. There were no limitations of race, ethnicity, primary language,
socio-economic status, or gender.
Exclusion criterion of this systematic review was the pediatric population (less
than 15 years of age) and meta-analysis studies.
Data Collection
The data collected for this systematic review included the variables of: design,
sample size, the procedure performed, and the concentration of O2 used during surgery.
The outcome variables identified were the incidence of postoperative SSI related to high
concentration oxygen vs. normal concentration oxygen and the average length of stay.
The data collection template also included any limitations in the study. The data
collection templates used are labeled Table 1 and Table 2.
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Table 1. Study Specific Data
Method/
Design

Sample

Type of Surgical
procedure
performed

Anesthesia and
Post-operative
airway used during oxygen delivery
surgery

Table 2. Outcome Data Collection
Incidence of postoperative SSI

Outcome / mortality

Limitations

Critical Appraisal
Each journal article was appraised with the Critical Appraisal Skills Programme
(CASP, 2017). The CASP appraisal tool for randomized controlled trials (Table 3) is a
10-question checklist to help appraise literature to determine if it has reliable and relevant
evidence. The CASP appraisal tool for case controlled trials, similar to the CASP
appraisal tool for randomized control trails listed above, is a 11-question checklist to help
appraise literature to determine if it has reliable and relevant evidence (Table 4). Both
CASP appraisal tools question three essential aspects of a study: Is the study valid? What
are the results? Are the results useful? The CASP checklist was used to evaluate the
scientific integrity of the studies. The use of the CASP appraisal tools and clinical
judgment helped determine if the journal article was of clinical importance to this
systematic review. The CASP checklist is free to use under the Creative Commons
license, and no approval was needed for its use.
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Table 3. CASP Checklist for Randomized Controlled Trials (CAPS, 2017)
Question

Yes

Can’t
Tell

No

Did the trial address a clearly focused issue?
Was the assignment of patients to treatments randomized?
Were all of the patients who entered the trial properly accounted for at its
conclusion?
Were patients, health workers and study personnel blinded?
Were the groups similar at the start of the trial?
Aside from the experimental intervention, were the groups treated equally?
How large was the treatment effect?
How precise was the estimate of the treatment effect?
Can the results be applied in your context? (Or to the local population?)
Were all clinically important outcomes considered?
Are the benefits worth the harms and costs?
Table 4. CASP Checklist for Case Controlled Study (CAPS, 2017)
Question
Did the trial address a clearly focused issue?
Did the authors use an appropriate method to answer their question?
Were the cases recruited in an acceptable way?
Were the controls selected in an acceptable way? The study
Was the exposure accurately measured to minimize bias?
Aside from the experimental intervention, were the groups treated equally
Have the authors taken account of the potential confounding factors in the design
and/or in their analysis?
How large was the treatment effect?
How precise was the estimate of the treatment effect?
Do you believe the results?
Can the results be applied to the local population?
Do the results of this study fit with other available
evidence?
Next, the results will be presented.

Yes

Can’t
No
Tell
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Results
A comprehensive literature search was conducted using electronic bibliographic
databases as described in the search strategy section. The PRISMA Flowchart was used
for a visual display of the search conducted and the results can be seen on the next page.
The first search resulted in 1,510 journal articles. After duplicates were removed there
was 135 journal articles identified. All 135 articles abstracts were read for relevance and
127 were excluded for not being relevant to this systematic review. Of the eight
remaining articles, two were excluded for being meta-analysis articles. One article was
identified using the reference list of an article that was included in this systematic review
(Figure 4).

Identification
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Records identified through

Additional records identified

database searching

through other sources

(n =1,510)

(n = 1)

Screening

Records after duplicates removed
(n =135)

Records excluded
Records screened

(n =127)

Eligibility

(n = 135)

Full-text articles assessed
for eligibility

Included

(n = 8)

Studies included in
quantitative synthesis
(n = 6)

Figure 4. PRISMA Flowchart (Moher et al., 2009)

Full-text articles excluded,
with reasons
(n = 2)
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Review of Included Studies
A study by Greif et al. (2000) (Appendix A-1) tested the hypothesis that
supplemental administration of oxygen during the perioperative phase would decrease the
incidence of SSI. The RCT included 500 adults aged 18-80 undergoing elective open
colorectal resection with general inhalational anesthesia via an ETT. The groups were
split into a control group and a treatment group by a computer-generated random
assignment. The two groups were then blinded from all but the anesthesia provider. The
control group consisted of 250 patients assigned to receive 30% O2 intraoperative vs. the
treatment group that consisted of 250 patients assigned to receive 80% O2 intraoperative.
Once the intraoperative phase was complete, both groups received a sealed nonrebreathing face mask for two hours postop and O2 was titrated to maintain an O2
saturation of 92%.
Outcomes for this study (Appendix B-1) showed that 28 patients (11.2%) in the
control group developed a SSI vs. 13 patients (5.2%) in the treatment group (P = 0.01).
Greif et al. (2000) also examined the average length of hospital stay and found that the
control group had an average stay of 11.9 (+ 4.0) days in the hospital vs. the treatment
group with an average stay of 12.2 (+ 6.1) days in the hospital (P = 0.26). The authors
also examined the mortality rate at 15 days postoperative and found that the control group
had six patients (2.4%) that died within the 15 days after surgery vs. the treatment group
which had one patient (0.4%) die within the 15 days after surgery (P= 0.13). Limitations
to this study were patients that enrolled in the study who had a smoking history, low
preoperative hemoglobin concentration, co-existing systemic disease, or drug therapy, all
of which could have influenced wound healing.
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When evaluating the study utilizing CASP (Appendix C-1), the RCT addressed a
clearly focused issue, all patients involved in the study were randomized and both groups
were similar at the start of the trial. Aside from the experimental intervention, both
groups were treated equally throughout the study. The treatment effect was not explicitly
mentioned in this study. A limitation of this study was not all of the patients were
accounted for at the 30-day follow up visit. Three patients did not return for follow up
visits; however, the authors stated that the patients had no known infections at discharge
from the hospital and were considered uninfected in the analysis. The results of the study
can be applied to intraabdominal surgery that requires general anesthesia with an ETT.
A study by Pryor et al. (2004) (Appendix A-2) examined whether the routine use
of high O2 during the perioperative period would alter the incidence of SSI in general
surgical patients. The RCT consisted of 160 adults over the age 18 undergoing major
intra-abdominal surgical procedures including colectomy (right, left, hemicolectomy, and
sigmoid), lower anterior resection, abdominoperineal resection, gastrectomy pancreaticoduodenectomy, exploratory laparotomy, and extensive gynecological procedures. All
surgeries were done under general anesthesia with an ETT. The RCT was blinded to all
involved except the anesthesia provider who was aware of the percent of O2 being
delivered. The groups were made up of a treatment group that received 80% O2
intraoperative and a control group that received 35% O2 intraoperative. Patients in the
treatment group were transported from the operating room with either a closed reservoir
bag-mask system or a Jackson-Rees modified Mapleson E circuit at an O2 flow rate of 10
liters per minute. Once in the PACU, the treatment group was fitted with a non-rebreather
mask and 80% O2 was administered for the next two hours. Patients in the control group
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were transported from the OR with nasal cannula at an O2 flow rate of 4 liters per minute.
Once in the PACU, the control group was fitted with a non-rebreather mask and 35% O2
was administered for the next two hours.
Outcomes for the study (Appendix B-2) showed that 20 patients (25%) in the
treatment group developed a SSI vs. nine patients (11.3%) in the control group (P = 0.02).
While this study is statically significant, the findings are limited to a difference of only 11
patients. Pryor et al. (2004) also examined the average length of hospital stay and found
that the treatment group had an average of 8.3 days vs. the control group that had an
average of 6.4 days (P = 0.07). The authors did not measure mortality. Limitations to this
study were numerous patient conditions that could affect wound healing, including a
smoking history, ASA physical class status, vital signs, lab values, and the presence of a
significant co-morbidity (diabetes, asthma, hypertension, coronary artery disease, obesity,
chronic obstructive pulmonary disease, end-stage renal disease or immunosuppression).
This study deliberately permitted variation in their anesthetic and surgical management to
model routine practice. This study also used a very heterozygous surgical population. The
small sample size, varying anesthetic management, and heterozygous surgical population
may be the reason for their contradictory results.
When evaluating the study utilizing CASP (Appendix C-2), the RCT addressed a
clearly focused issue, all patients involved in the study were randomized, and both groups
were similar at the start of the trial. This study accounted for variability and a variety of
anesthetic management and deliberately permitted variation in anesthetic and surgical
management to model routine practice. The treatment effect included 300 patients using
the Lan-Demets a spending function approach, with an interim analysis of the first 160
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patients. The analysis assessed an overall risk of 0.05 for type I error and 0.20 for type II
error and a detectable treatment effect of 40%. This study demonstrated that a higher O2
concentration might be damaging to a patient and have adverse effects. The results of the
study can be applied to intraabdominal surgery that requires general anesthesia.
A study by Belda et al. (2005) (Appendix A-3) tested the hypothesis that
supplemental O2 would reduce infection risk in patients following colorectal surgery. The
RCT consisted of 300 patients aged 18-80 undergoing elective colorectal surgery with
general inhalational anesthesia via an ETT. The RCT was a double blinded study to all
those involved except the anesthesia provider that was aware of the percent of O2 being
delivered. The groups were randomly assigned by computer-generated codes to receive
either 30 or 80% O2 intraoperatively and for six hours after surgery. The groups were
made up of a treatment group that had 148 patients that received 80% O2 intraoperative
and a control group with 143 patient that received 30% O2 intraoperative. All patients
received 100% O2 during the extubation. Following extubation, during the 6-hour postoperative period, patients in the control group received 30% O2 while the treatment group
received 80% O2 via a non-rebreathing face mask at a flow of 16 liters per minute.
Outcomes for the study (Appendix B-3) showed that 22 patients (14.9%) in the
treatment group developed a SSI vs. 35 patients (24.4%) in the control group (P=0.4).
The risk of SSI was 39% lower in the treatment group (RR, 0.61; 95% confidence
interval [CI], 0.38 – 0.98) vs. the control group. The authors also examined how many
patients required hospitalization after surgery and found that 11.7 patients (7.0%) in the
treatment group required hospitalization vs. 10.5 patients (4.4%) in the control group (P=
0.9). Two patients died during the study, and they were both in the control group.
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Limitations to this study were the small sample size, lack of a diagnostic tool used to
define SSI, and SSI was only examined for the first 15 days postoperatively unlike other
studies that followed the patient for 30 days.
When evaluating the study utilizing CASP (Appendix C-3), the RCT addressed a
clearly focused issue, all patients involved in the study were randomized, and both groups
were similar at the start of the trial. Aside from the experimental intervention, both
groups were treated equally throughout the study. The treatment effect was not explicitly
mentioned in this study. Not all the clinically important outcomes were considered. The
study failed to look at 30-day post-operative SSI and mortality. While the sample size
was less than similar studies and the follow-up evaluation for SSI was at 15 days as
compared to most other studies at 30 days, the findings can still be applied to patients
undergoing intraabdominal surgery with general anesthesia.
A study by Meyhoff et al. (2009) (Appendix A-4) examined whether the use of
80% O2 during surgery reduced the frequency of SSI without increasing the frequency of
pulmonary complication in patients undergoing abdominal surgery. The RCT included
1400 adults over the age of 18 who underwent an acute or elective laparotomy with
inhalational or total intravenous anesthesia that required an ETT. The treatment group
consisted of 685 patients assigned to receive 80% O2 during the intraoperative phase. The
control group consisted of 701 patients assigned to receive 30% O2 during the
perioperative phase. Both groups were placed on a non-rebreather mask for two hours
during the postoperative phase. The groups did differ in their O2 delivery during the next
two hours in the Post-Anesthesia Care Unit (PACU). The treatment group received 14L
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of O2 and 2L of air per minute in the PACU vs. the control group that received 2L of O2
and 14L of air per minute for two hours postoperative.
The outcomes for this study (Appendix B-4) showed that 131 patients (19.1%) in
the treatment group developed SSI vs. 141 patients (20.1%) in the control group (P=
0.64) ([CI]0.94). The authors also found that 30 patients (4.4%) in the treatment group
died before the 30-day follow up period vs. 20 patients (2.9%) control group (P = 0.15).
Limitations to this study included the lack of an optimized regimen of antibiotics
and the prevention of hypothermia could not be controlled for in all of the patients during
the trial. Also, 51 of the 701 (7.3%) patients that received 30% O2 required a FiO2 of 0.60
or greater for more than an hour to maintain O2 saturations above 94% during surgery,
which should have excluded them from this subset. The study did exclude patients who
had surgery within 30 days, were taking chemotherapy for malignancy within the past
three months, or O2 saturations below 90% in the preoperative phase.
When evaluating the study utilizing CASP (Appendix C-4), the RCT addressed a
clearly focused issue, all patients involved in the study were randomized, and both groups
were similar at the start of the trial. Aside from the experimental intervention, both
groups were treated equally throughout the study. The treatment effect was not explicitly
mentioned in this study. A limitation of this study was not all of the patients were
accounted for at the 30-day follow up visit. One hundred fifty-seven of the 1386 (11.3%)
did not have a follow-up visit between the 13th and 30th postoperative day. The results of
the study can be applied to intraabdominal surgery that requires general anesthesia with
an ETT.
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A study Bickel et al. (2011) (Appendix A-5) examined the influence of
hyperoxygenation on surgical site infection by using a homogenous study population.
The RCT consisted 210 adults, defined as 15 years of age or older, undergoing intraabdominal surgery homogenous for open appendectomy, which is a type of
intraabdominal surgery to treat an acute appendicitis. The surgery was performed under
general inhalational anesthesia with an ETT. The RCT was double blinded. The two
groups were made up of 107 patients in the treatment group assigned to receive 80% O2
intraoperative and 103 patients in the control group assigned to receive 30% O2
intraoperative. The treatment group received high flow O2 (O2 flow rate of 10 liters per
minute) via a non-rebreather mask with a reservoir for two hours while in PACU while
the control group received O2 at a flow rate of 4 liters per minute via nasal cannula.
Outcomes for the study (Appendix B-5) showed that six subjects (5.6%) in the
treatment group developed a SSI vs. 14 (13.6%) in the control group (P = 0.04). The
authors also examined the mean length of hospital stay and found the treatment group had
an average stay of 2.51 days (+0.88) vs the control group that had an average length of
hospital stay 2.92 (+1.51) (P = 0.01). This study didn’t not measure mortality rates.
Limitations to this study included patients in PACU didn’t have the anesthesia provider
closely monitoring the delivery of O2, as they had been doing intra-operatively. Also,
patients with a smoking history, low preoperative hemoglobin concentration, co-existing
systemic disease, and drug therapy could influence wound healing.
When evaluating the study utilizing CASP (Appendix C-5), the RCT addressed a
clearly focused issue, all patients involved in the study were randomized, and both groups
were similar at the start of the trial. Aside from the experimental intervention, both
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groups were treated equally throughout the study. The treatment effect was not explicitly
mentioned in this study. The results of the study can be applied to intraabdominal surgery
that requires general anesthesia with an ETT.
A study by Kurz et al. (2018) (Appendix A-6) tested the hypothesis that
supplemental O2 would reduce the risk of a 30-day composite of deep tissue or organspace SSI, healing-related wound complications, and mortality. The controlled trial took
place at a colorectal surgery center and consisted of 5749 colorectal surgeries lasting over
two hours, on adults over the age of 18 that received general inhalational anesthesia with
an ETT. Qualifying colorectal operations included 2843 colorectal resections, 1866 lower
GI therapeutic procedures, 373 small bowel resections, and 667 other colorectal
procedures. The controlled trial consisted of 2896 patients in the treatment group
assigned to receive 80% O2 intraoperative and 2853 patients in the control group assigned
to receive 30% O2 intraoperative. The first two weeks of the study, the groups were
randomized by a statistician, but the subsequent 38 months were not randomized, and the
provider decided the concentration of 02 delivered.
Outcomes for the study (Appendix B-6) showed that 118 patients (4.1%) in the
treatment group developed SSI vs. 112 patients (3.9%) in the control group (P = 0.77,
[CI] 1.04 (0.74-1.46). While examining mortality, the authors found that 20 patients
(0.7%) died within the 30 days after surgery in the treatment group vs.10 patients (0.4%)
in the control group (P = 0.85, [CI] 1.97 (0.71-5.47). The outcomes for this study were
abstracted from a billing department using medical records rather than evaluation by the
investigators. Limitation of this study included the evaluation of SSI via chart review; “a
small fraction” (Kurz et al., 2018) of the patients could not be accounted at 30 days post-
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operative because they had follow-up care at other facilities not included in this study.
Also, the use of positive end-expiratory pressure (PEEP) by the anesthesia provider was
not accounted.
When evaluating the study utilizing CASP (Appendix C-6), this controlled trial
clearly addressed a focused issue. The authors used appropriate methods to answer their
question and the cases were selected from a colorectal center that performed many
intraabdominal surgeries daily. The treatment effect was not explicitly mentioned in this
study. The authors failed to minimize bias when they discontinued the randomization of
groups after two weeks. A statistician randomized the first two weeks of the study, but
the subsequent 38 months were not randomized and the concentration of 02 delivered was
decided by the provider to maximize patient safety rather than randomization. Aside from
experimental intervention, the two groups were treated equally. The authors didn’t take
into account the use of positive end expiratory pressure (PEEP) by the anesthesia
provider in the design. The study allowed the control group to receive more than 30% O2
when a patient’s O2 saturation fell below 95% to maximize patient safety, creating the
potential for confounding factors in the analysis. For these reasons, concerns about
confidence in study findings exist and findings should not be applied to the general
population. The results of this study are in opposition to most other studies. Also,
findings do not fit with other available evidence and research completed by the same
group a couple of years earlier.
Cross-Study Analysis
For this systematic review, the central elements of each journal article were
extracted to analyze critical variables across the different studies (Appendix D). The
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elements and data collected included the specific treatment used, including the percent of
O2 each group was administered, the SSI rate by group, and the mortality rate. All of the
studies used in this systematic review were similar in that the treatment groups all
received 80% O2, and the control groups received 30-35% O2 during intraabdominal
surgery under general anesthesia with an ETT. All the studies differed in many ways
including the number of patients, whether the research was blinded, the amount of time
spent collecting patient data and outcomes, the specific outcomes examined, and the
method of O2 delivery in the PACU all varied amongst the studies. The one finding that
all the studies reviewed was whether an increase in O2 during the perioperative phase
resulted in an increase or decrease in SSI.
The studies by Greif et al. (2000), Meyhoff et al. (2000), Belda et al. (2005), and
Bickel et al. (2011) all showed a decrease in SSI (P = 0.01; P= 0.64; P=0.4; and P = 0.04
respectively) in their treatment groups that received 80% O2 intraoperative during
intraabdominal general surgery. Conflicting studies by Pryor et al. (2004), and Kurz et al.
(2018) found their treatment groups had an increased risk of SSI (P = 0.02; P = 0.77
respectively). The statistically significant studies by Greif et al. (2000) and Bickel et al.
(2011) showed a decrease in SSI, contradicting the findings by Pryor et al. (2004) that
showed an increase in SSI. The two fundamental differences in these studies were the
size of the patient population and the type of surgery performed. Greif et al. (2000)
studied 500 patients undergoing elective open colorectal resection, and Bickel et al.
(2011) studied 210 patients undergoing open appendectomy for acute appendicitis. Pryor
et al. (2004) studied 160 undergoing major intra-abdominal surgical procedures including
colectomy (right, left, hemicolectomy, and sigmoid), lower anterior resection,
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abdominoperineal resection, gastrectomy pancreaticoduodenectomy, exploratory
laparotomy, and extensive gynecological procedures. Meyhoff et al. (2000) and Bickel et
al. (2011) both had a larger population compared to Greif et al. (2000). Meyhoff et al.
(2000) and Bickel et al. (2011) also studied only one specific type of intra-abdominal
surgery, making their making studies generalizable only to that type of surgery.
A second variable examined across a majority of the studies was mortality. A
direct causal relationship between SSI and mortality is difficult to examine because there
are many variables involved with mortality such as co-existing diseases, patient age,
patient health prior to surgery, and the availability to quality health care to name a few.
Studies by Greif et al. (2000) (P= 0.13) and Belda et al. (2005) (no P value given)
reported a decrease in mortality in their treatment groups whereas studies by Meyhoff et
al. (2000) and Kurz et al. (2018) reported an increase in the mortality rate in the treatment
groups (P = 0.15; P = 0.85 respectively). There was no level of significance amongst the
studies in regard to mortality. Bickel et al. (2011) and Pryor et al. (2004) both chose not
to examine mortality in their studies, perhaps due to the fact that mortality has many
variables and it would be difficult to account for them all.
Next, the summary and conclusions will be presented.
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Summary and Conclusions
Surgical site infections cost billions of dollars a year to treat and put a strain on
patients and the health care system (CDC, 2017). The potential for improved patient care
and reduced healthcare spending by decreasing SSIs could save millions of US healthcare
dollars and at the same time lead to better patient outcomes. The WHO (2016)
recommended the use of high concentration oxygen throughout the intraoperative phase
to decrease SSI. The correct concentration of O2 to administer during surgery is
influenced by many factors such as the patient condition, the provider’s preference, and
perhaps an unwritten standard at a facility. Some facilities, due to varying standards of
equipment, may not have O2 piped into the anesthesia machines, forcing them to rely prefilled canisters during surgery. In the US it is typical for an Advanced Practicing
Registered Nurse (APRN) CRNA to titrate the concentration of O2 down to a minimum
while maintaining an O2 saturation of 94% or better during surgery. Because current
practice regarding O2 use differs from the WHO guidelines, and the evidence they used to
make this recommendation can be considered inconclusive, there has been a discussion
amongst anesthesia providers as to whether this is the best practice to follow.
The focus of this systematic review was to determine whether high concentration
oxygen delivered to surgical patients undergoing intra-abdominal surgery decreases SSI.
Pasteur’s Germ Theory and PRISMA were used to guide this systematic review. A total
of six studies were identified and used for this review which can be visualized with the
PRISMA flow sheet. All six studies were then evaluated using the CASP tool and data
extraction tables were created. Comparison tables were also created, and a cross study
analysis of data was completed.
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Studies by Greif et al. (2000), Meyhoff et al. (2000), Belda et al. (2005), and
Bickel et al. (2011) all showed a decrease in SSI, but only the studies by Greif et al., and
Bickel et al. reported statistical significance with a P value of less than 0.05.
Contradictory to these studies was a smaller, but well-designed review by Pryor et al.
(2004) that showed a statically significant increase in SSI. This study is often referenced
in other works as the outlier and the reason why more studies are needed before a strong
recommendation can be given endorsing the use of high concentration O2. The WHO
(2016) did not include this study in their meta-analysis of evidence-based research.
Limitations to this systematic review included the most current available
evidence, moderate sample size of studies, time limitations to conduct this review, and
the novice status of the researcher who conducted it. Articles that were not controlled
trials available in full text or in a foreign language was excluded. The six studies used for
this systematic review had a combined total sample of 8296 patients. Two thirds of the
total sample (n = 5749) came from the Kurz et al. (2018) study alone. The other five
studies had a combined total of 2547 subjects. More large-scale studies like the Kurz et
al. study are needed to further examine the use of high concentration O2. With more time,
perhaps articles not in full text could have been obtained and included in this review.
The WHO (2016) guideline recommending the use of high concentration oxygen
during intraabdominal surgery to decrease SSI will inevitably generate more research that
will test the guideline. Addition studies will generate new hypothesis and more raw data
to be used in the continued evaluation of this guideline. Based on all the available
research at this time, the WHO’s (2016) recommended guideline related to use of high
concentration oxygen during the intraoperative phase to decrease SSI should be followed
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if patient specifics and facility resources allow. Further studies will need to focus on
standardized protocols specific for each abdominal surgery.
Next, the recommendations and implications for advanced nursing practice will
be presented.
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Recommendations and Implications for Advanced Nursing Practice
Prevention of SSI requires timely interventions by multiple clinicians during a
patient’s care to prevent infection. One of the best and simplest ways to prevent infection
is the act of washing germs off one’s hands. The practice of hand washing originated
from Pasteur’s Germ Theory which demonstrated that germs cause infection. When
handwashing was utilized prior to surgical dressing changes by bedside RNs, infection
rates significantly decreased. In addition, surgeons can decrease SSI by scrubbing their
hands and wearing sterile gloves, gowns and a mask during surgery. The CRNA may
have the greatest opportunity to prevent SSI with the administration of the appropriate
antibiotics just prior to skin incision.
Over a century has passed since the introduction of the Germ theory and medicine
continues to improve strategies for decreasing bacteria and thus infection. The WHO has
implemented guidelines to help decrease SSI and subsequently reducing health care costs.
Following these recommendations could potentially save billions of dollars. Not only will
the APRN CRNAs need to adopt this change in practice but they will also need to inform
other members of the interdisciplinary team of the current evidence-based practice
recommendations. The APRN is an integral part of the interdisciplinary team, which
includes the surgeon and anesthesiologist. There are times when APRN must follow the
surgeon, and/or the anesthesiologist’s order regarding O2 concentration administration
during surgery. The APRN can confidently include evidence-based studies in their
decision-making process, which is generally well-received by the interdisciplinary team.
This systematic review yielded evidence-based results that can be utilized specifically by
the APRN CRNA to help guide the decision related to the correct O2 concentration to use
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during intra-abdominal surgery. Research has shown that the use of high concentration
O2 does have benefits and the APRN CRNA will be in a position to share the evidencebased research to the interdisciplinary team.
The American Association of Nurse Anesthetists (AANA) provides CRNAs
access to unparalleled professional resources. Membership in AANA includes live and
online continuing education as well as a bi-monthly professional journal of trending
topics. The AANA annual conference is the ideal arena to inspire association
involvement. Presentation of well-designed meta-analysis on high concentration oxygen
use could have unmatched opportunities to reach the most extensive collection of
CRNAs. The AANA online continuing education classes could incorporate the most up
to date research and recommended guidelines on this topic. The bi- monthly journal
could help publicize the topic by publishing the newest RCTs that examine high
concentration O2 use perioperatively. It will be the responsibility of the CRNA to
disseminate and promote this evidence-based research in their daily practice. The CRNAs
in developed countries such as the U.S. have an abundance of available recourses
compared to undeveloped parts of the world and they will be in a critical position to
guide this ongoing research.
The pendulum of evidence is starting to swing towards the use of high
concentration O2 to help decrease the rate of SSI. Guidelines are meant to guide practice
not dictate it. With the current evidence available, it would be premature to institute a
policy that dictates the use of high concentration O2 during intra-abdominal surgery. Any
policy that dictates and limits the autonomy of practice will be a hard sell to a practicing
CRNA. Until more meta-analysis and evidence-based research demonstrate decreased

50

SSI with the use of high concentration O2, the recommended guidelines are precisely that:
guidelines not policy. Clearly, further research is needed to explore this important topic.
Specifically, research that examines toxicity related to high concentration oxygen.
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Appendix A
Table A-1. Study Specific Data
Greif, R., Akça, O., Horn, E., Kurz, A., & Sessler, D. I. (2000). Supplemental perioperative oxygen to reduce the incidence of
surgical-wound nfection. New England Journal of Medicine, 342(3), 161-167.
Method/ Design

Sample

RCT, computer generated
random assignment of groups.
Blinded study from all but the
anesthesia provider.
Independent physicians (not
part of the surgical team)
evaluated the wounds daily.

500 adults aged 18-80:
250 assigned to receive
80% O2 intraoperative;
250 assigned to receive
30% O2 intraoperative.

Type of
Surgical
procedure
performed
Elective open
colorectal
resection

Anesthesia and Post-operative oxygen delivery
airway used
during surgery
General
inhalational
anesthesia with
an ETT

All patients received a sealed nonrebreathing face mask for two hours
postop. Oxygen was titrated to
maintain O2 saturation of 92% in both
groups.
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Appendix A
Table A-2. Study Specific Data
Pryor, K. O., Iii, T. J., Lien, C. A., & Goldstein, P. A. (2004). Surgical site infection and the routine use of perioperative hyperoxia in
a general surgical population. JAMA, 291(1), 79-87.
Method/ Design

Randomized
control trial,
double blinded;
only the
anesthesia
provider was
aware of the
groups.

Sample

Type of Surgical
procedure performed

Anesthesia
and airway
used during
surgery
160 adults
Major intra-abdominal General
over the age
surgical procedures
inhalational
18:
including colectomy
anesthesia
80 assigned to (right, left,
with an ETT
receive 80%
hemicolectomy, and
O2
sigmoid), lower
intraoperative; anterior resection,
80 assigned to abdominoperineal
receive 35%
resection, gastrectomy
O2
pancreaticointraoperative. duodenectomy,
exploratory
laparotomy, and large
gynecological
procedures

Post-operative oxygen delivery

Patients in the 80% O2 group were transported from
the operating room with either a closed reservoir
bag-mask system or a Jackson-Rees modified
Mapleson E circuit at an oxygen flow rate of 10
liters per minute; once in the PACU the group was
fitted with a non-rebreather mask and 80% O2 was
administered for the next two hours.
Patients in the 35% O2 group were transported from
the OR with nasal cannula at an oxygen flow rate of
4 liters per minute; once in the PACU the group was
fitted with a non-rebreather mask and 35% O2 was
administer for the next two hours.
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Appendix A
Table A-3. Study Specific Data
Belda, F. J., Aguilera, L., García de la Asunción, J., Alberti, J., Vicente, R., Ferrándiz, L., . . . Ortí, R. (2005). Supplemental
perioperative oxygen and the risk of surgical wound infection a randomized controlled trial. JAMA, 294(16), 2035-2042.
Method/ Design

Sample

Double blind randomized control
trial;
patients were randomly assigned by
computer generated codes to
receive either 30 or 80% O2
intraoperatively and for 6 hours
after surgery
Blinded study from all but the
anesthesia provider.

300 patients
aged 18-80:
143 patients
received 30%
O2 ;
148 patients
received 80%
O2 .

Type of
Surgical
procedure
performed
Elective
colorectal
surgery

Anesthesia
and airway
used during
surgery
General
inhalational
anesthesia
with an ETT

Post-operative oxygen delivery

All patients received 100% O2 during the
extubation.
During the 6-hour postoperative period, patients
received either a 30% O2 or 80 % O2 via a nonrebreathing face mask at a flow of 16 liters per
minute.
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Appendix A
Table A-4. Study Specific Data
Meyhoff, C. S., Wetterslev, J., Jorgensen, L. N., Henneberg, S. W., Høgdall, C., Lundvall, L., Group, F. T. (2009). Effect of high
perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery. JAMA, 302(14), 15431550.
Method/ Design

Sample

Type of
Surgical
procedure
performed
PROXI trial: patient Adults over the age of Acute or
and observer-blinded 18;
elective
randomized clinical
1400 patients: 685
laparotomy
trial
assigned to receive
80% O2; 701 assigned
to receive 30% O2.

Anesthesia and airway
used during surgery

Post-operative oxygen delivery

Inhalational or total
Both groups were placed on a nonintravenous anesthesia with rebreather mask for two hours post
an ETT
op.
80% O2 group received 14L of
oxygen and 2L of air per minute;
30% O2 group received 2L of oxygen
and 14L of air per minute.
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Appendix A
Table A-5. Study Specific Data
Bickel, A. (2011). Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis. Archives of
Surgery,146(4), 464-470.
Method/ Design

Sample

Type of Surgical
procedure performed

Randomized double
blinded controlled
trial;
homogenous for one
specific type of
intra-abdominal
surgery

210 adults (defined as
15 years of age or
older):
107 assigned to receive
80% O2 intraoperative;
103 assigned to receive
30% O2 intraoperative.

Open appendectomy
for acute appendicitis

Anesthesia and
airway used
during surgery
General
inhalational
anesthesia with
an ETT

Post-operative oxygen delivery
Patients in the 80% O2 group received
high flow O2 (O2 flow rate of 10 liters
per minute) via a non-rebreather mask
with a reservoir for 2 hours.
Patients in the 30% O2 group received
O2 at a flow rate of 4 liters per minute
via nasal cannula.
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Appendix A
Table A-6. Study Specific Data
Kurz, A., Kopyeva, T., Suliman, I., Podolyak, A., You, J., Lewis, B., . . . Sessler, D. (2018). Supplemental oxygen and surgical-site
infections: An alternating intervention controlled trial. British Journal of Anaesthesia,120(1), 117-126.
Method/ Design

Sample

Controlled trial at a colorectal
surgery center;
evaluation by staff via chart
review.
First two weeks of the study
were randomized by a
statistician, but the subsequent
38 months were not randomized
and the concentration of 02
delivered was decided by the
provider.

5749 colorectal
surgeries on adults
aged over 18years
old:
2896 assigned to
receive 80% O2
intraoperative;
2853 assigned to
receive 30% O2
intraoperative.

Type of Surgical procedure
performed
Major intestinal surgery
lasting at least two hours:
qualifying operations
included 2843 colorectal
resections, 1866 lower GI
therapeutic procedures, 373
small bowel resections, 667
other colorectal procedures.

Anesthesia and airway
used during surgery
General inhalational
anesthesia with an ETT

Post-operative
oxygen delivery
Not addressed
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Table B-1. Outcome Data Collection
Greif, R., Akça, O., Horn, E., Kurz, A., & Sessler, D. I. (2000). Supplemental perioperative oxygen to reduce the incidence of
surgical-wound infection. New England Journal of Medicine, 342(3), 161-167.
Incidence of
postoperative SSI

Outcome / mortality

Limitations

13 (5.2%) in the 80%
O2 group developed
SSI;
28 (11.2%) in the 30%
O2 group developed SSI
(P = 0.01)

Length of hospital stay 12.2 (+ 6.1) for
the 80% O2 group;
Length of hospital stay 11.9 (+ 4.0) for
the 30% O2 group (P = 0.26);
1 patient (0.4%) died within the 15 days
after surgery in the 80% O2;
6 patients (2.4%) died within the 15 days
after surgery in the 30 % O2. (P= 0.13)

Patients with a smoking history, low preoperative hemoglobin
concentration, co-existing systemic disease, and drug therapy
could have influenced wound healing.
Follow up evaluations of wounds were not completed in three
patients at the 30-day follow up visit. They had no known
infections and were considered uninfected in the analysis.
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Table B-2. Outcome Data Collection
Pryor, K. O., Iii, T. J., Lien, C. A., & Goldstein, P. A. (2004). Surgical site infection and the routine use of perioperative hyperoxia in
a general surgical population. JAMA, 291(1), 79-87.
Incidence of postoperative SSI

Outcome / mortality

Limitations

20 (25%) in the 80% O2 group
developed SSI;
9 (11.3%) in the 35% O2 group
developed SSI.
(P = 0.02)

Length of hospital stay 8.3
days for the 80% O2 group;
Length of hospital stay 6.4 day
for the 35% O2 group.
(P = 0.07)
Mortality was not measured.

Numerous conditions could affect wound healing including a
smoking history, ASA physical class status, vital signs, lab
values, the presences of a major co-morbidity (diabetes,
asthma, hypertension, coronary artery disease, obesity, chronic
obstructive pulmonary disease, end stage renal disease or
immunosuppression).
Unable to detect if other elements of anesthetic management
might affect SSI. This study deliberately permitted variation in
anesthetic and surgical management to model routine practice.
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Table B-3. Outcome Data Collection
Belda, F. J., Aguilera, L., García de la Asunción, J., Alberti, J., Vicente, R., Ferrándiz, L., . . . Ortí, R. (2005). Supplemental
perioperative oxygen and the risk of surgical wound infection a randomized controlled trial. JAMA, 294(16), 2035-2042.
Incidence of
postoperative SSI

Outcome / mortality

Limitations

22 (14.9%) in the 80%
O2 group developed SSI;
35 (24.4%) in the 30%
O2 group developed SS.
(P=0.4)
The risk of SSI was 39%
lower in the 80% O2
group (RR, 0.61; 95%
confidence interval [CI],
0.38 – 0.98) vs the 30%
O2 group.

11.7 (7.0%) required
hospitalization after surgery in the
80% O2 group;
10.5 (4.4%) required
hospitalization after surgery in the
30% O2 group
(P= 0.9);
only 2 patients died during the
study and they were both in the
30% O2 group.

Small sample size;
Diagnostic tool used to define SSI included purulent drainage
whether or not it was tested for organisms.
Only looked at SSI for the first 15 days post operatively unlike
other studies that followed the patient for 30 days.
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Table B-4. Outcome Data Collection
Meyhoff, C. S., Wetterslev, J., Jorgensen, L. N., Henneberg, S. W., Høgdall, C., Lundvall, L., Group, F. T. (2009). Effect of high
perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery. JAMA, 302(14), 15431550.
Incidence of postoperative
SSI

Outcome / mortality

Limitations

131 (19.1%) in the 80% O2
group developed SSI;
141 (20.1%) in the 30% O2
group developed SSI.
(P= 0.64) ([CI]0.94)

30 (4.4%) in the 80% O2 group
died before the 30-day follow up
period;
20 patients (2.9%) in the 30% O2
group died before the 30-day
follow up period (P = 0.15).

Excluded patient who had surgery within 30 days, taking chemo
therapy for malignancy within the past 3 months, oxygen
saturations below 90% in the pre-operative phase.
An optimized regimen of antibiotics and the prevention of
hypothermia could not be controlled for in all of the patients
during the trial.
51 of the 701 (7.3%) patients that received 30% O2 required an
FiO2 of 0.60 or greater for more than an hour to maintain O2
saturations above 94% during the trial, which would should
have excluded them from this subset.
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Table B-5. Outcome Data Collection
Bickel, A. (2011). Perioperative hyperoxygenation and wound site infection following surgery for acute appendicitis. Archives of
Surgery,146(4), 464-470.
Incidence of postoperative SSI

Outcome / mortality

Limitations

6 (5.6%) in the 80% O2 group
developed SSI;
14 (13.6%) in the 30% O2 group
developed SSI
(P = 0.04)

Mean length of hospital stay 2.51
(+0.88) in the 80% O2 group;
Length of hospital stay 2.92 (+1.51) of
the 30% O2 group
(P = 0.01).
Mortality was not measured.

Patients in PACU didn’t have the anesthesia provider
closely monitoring the delivery O2, as they did intraoperatively.
Patients with a smoking history, low preoperative
hemoglobin concentration, co-existing systemic
disease, and drug therapy could influence wound
healing
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Table B-6. Outcome Data Collection
Kurz, A., Kopyeva, T., Suliman, I., Podolyak, A., You, J., Lewis, B., . . . Sessler, D. (2018). Supplemental oxygen and surgical-site
infections: An alternating intervention controlled trial. British Journal of Anaesthesia,120(1), 117-126.
Incidence of postoperative SSI

Outcome / mortality

Limitations

118 (4.1%) patients in the 80%
O2 group developed SSI;
112 (3.9%) patients of the 30%
O2 group developed SSI.
(P = 0.77, [CI] 1.04 (0.74-1.46)

20 patients (0.7%) died within
the 30 days after surgery in the
80% O2;
10 patients (0.4%) died within
the 30 days after surgery in the
30% O2
(P = 0.85, [CI] 1.97 (0.715.47)

Outcomes were abstracted from a billing department rather
than evaluation by investigators;
some patients could not be accounted for because they had
follow-up care in other facilities not included in this study.
The use of PEEP was not accounted for.
Randomization of groups was discontinued after two weeks.
The first two weeks of the study were randomized by a
statistician, but the subsequent 38 months were not
randomized and the concentration of 02 delivered was decided
by the provider for added safety to the patient.
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Table C-1. Critical Appraisal Skills Programme (CASP) Randomized Control Trials
Checklist
Greif, R., Akça, O., Horn, E., Kurz, A., & Sessler, D. I. (2000). Supplemental
perioperative oxygen to reduce the incidence of surgical-wound infection. New England
Journal of Medicine, 342(3), 161-167.
Question

Yes

Did the trial address a clearly focused issue?

X

Was the assignment of patients to treatments randomized?

X

Can’t
No
Tell

Were all of the patients who entered the trial properly accounted for at its
conclusion? The authors state “most patients returned for the follow up visit X
at 14 days”
Were patients, health workers and study personnel blinded? Except the
Anesthesia provider due to safety concerns they had to know.

X

Were the groups similar at the start of the trial?

X

Aside from the experimental intervention, were the groups treated equally?

X

How large was the treatment effect?

X

How precise was the estimate of the treatment effect?

X

Can the results be applied in your context? (Or to the local population?)

X

Were all clinically important outcomes considered?

X

Are the benefits worth the harms and costs? The benefits of extra oxygen
resulted in a reduction in SSI and length of stay which was estimated to cost X
12,500 per case. The cost of extra oxygen is pennies.
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Table C-2. Critical Appraisal Skills Programme (CASP) Randomized Control Trials
Checklist
Pryor, K. O., Iii, T. J., Lien, C. A., & Goldstein, P. A. (2004). Surgical site infection and
the routine use of perioperative hyperoxia in a general surgical population. JAMA,
291(1), 79-87.
Question

Yes

Did the trial address a clearly focused issue?

X

Was the assignment of patients to treatments randomized?

X

Were all of the patients who entered the trial properly accounted for at its
conclusion?

X

Were patients, health workers and study personnel blinded? Except the
Anesthesia provider due to safety concerns they had to know.

X

Were the groups similar at the start of the trial?

X

Aside from the experimental intervention, were the groups treated equally? This
study deliberately permitted variation in anesthetic and surgical
management to model routine practice.
How large was the treatment effect? 300 patients using the Lan-Demets a
X
spending function approach, with an interim analysis of the first 160
patients.
How precise was the estimate of the treatment effect? The analysis assessed an
overall risk of 0.05 for type I error and 0.20 for type II error and a
X
detectable treatment effect of 40%
Can the results be applied in your context? (Or to the local population?)

X

Were all clinically important outcomes considered?

X

Are the benefits worth the harms and costs? The authors suggest that the
negative effects of a higher O2 concentration may be damaging to a patient.

Can’t
No
Tell

X

X
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Table C-3. Critical Appraisal Skills Programme (CASP) Randomized Control Trials
Checklist.
Belda, F. J., Aguilera, L., García de la Asunción, J., Alberti, J., Vicente, R., Ferrándiz, L.,
Ortí, R. (2005). Supplemental perioperative oxygen and the risk of surgical wound
infection a randomized controlled trial. JAMA, 294(16), 2035-2042.
Question

Yes

Did the trial address a clearly focused issue?

X

Was the assignment of patients to treatments randomized?

X

Were all of the patients who entered the trial properly accounted for at its
conclusion?

X

Were patients, health workers and study personnel blinded? Yes except for the
anesthesia provider

X

Were the groups similar at the start of the trial?

X

Aside from the experimental intervention, were the groups treated equally?

X

Can’t
No
Tell

How large was the treatment effect?

X

How precise was the estimate of the treatment effect?

X

Can the results be applied in your context? (Or to the local population?)

X

Were all clinically important outcomes considered? They didn’t examine death
rates, or 30-day infection rates
Are the benefits worth the harms and costs?

X
X
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Table C-4. Critical Appraisal Skills Programme (CASP) Randomized Control Trials
Checklist
Meyhoff, C. S., Wetterslev, J., Jorgensen, L. N., Henneberg, S. W., Høgdall, C.,
Lundvall, L., Group, F. T. (2009). Effect of high perioperative oxygen fraction on
surgical site infection and pulmonary complications after abdominal surgery JAMA,
302(14), 1543-1550.
Question

Yes

Did the trial address a clearly focused issue?

X

Was the assignment of patients to treatments randomized?

X

Can’t
No
Tell

Were all of the patients who entered the trial properly accounted for at its
conclusion? 157 of the 1386 (11.3%) did not have a follow up visit between
the 13th and 30th day

X

Were patients, health workers and study personnel blinded?

X

Were the groups similar at the start of the trial?

X

Aside from the experimental intervention, were the groups treated equally?

X

How large was the treatment effect

X

How precise was the estimate of the treatment effect?

X

Can the results be applied in your context? (Or to the local population?)

X

Were all clinically important outcomes considered?

X

Are the benefits worth the harms and costs? There was no increase in
pulmonary complication with the use of high O2 concentration.

X
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Table C-5. Critical Appraisal Skills Programme (CASP) Randomized Control Trials
Checklist
Bickel, A. (2011). Perioperative hyperoxygenation and wound site infection following
surgery for acute appendicitis. Archives of Surgery,146(4), 464-470.
Question

Yes

Did the trial address a clearly focused issue?

X

Was the assignment of patients to treatments randomized?

X

Were all of the patients who entered the trial properly accounted for at its
conclusion?

X

Were patients, health workers and study personnel blinded? Except for the
anesthesia provider

X

Were the groups similar at the start of the trial?

X

Aside from the experimental intervention, were the groups treated equally?

X

Can’t
No
Tell

How large was the treatment effect?

X

How precise was the estimate of the treatment effect?

X

Can the results be applied in your context? (Or to the local population?)

X

Were all clinically important outcomes considered?

X

Are the benefits worth the harms and costs?

X
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Table C-6. Critical Appraisal Skills Programme (CASP) Checklist for Case Controlled
Study.
Kurz, A., Kopyeva, T., Suliman, I., Podolyak, A., You, J., Lewis, B., . . . Sessler, D.
(2018). Supplemental oxygen and surgical-site infections: An alternating intervention
controlled trial. British Journal of Anaesthesia,120(1), 117-126.
Question

Yes

Did the trial address a clearly focused issue?

X

Did the authors use an appropriate method to answer their question?

X

Can’t
No
Tell

Were the cases recruited in an acceptable way?
X
Were the controls selected in an acceptable way? The study
X
Was the exposure accurately measured to minimize bias? No, the study had no
blinding, and they discontinued randomization after the first two weeks of
the study.
Aside from the experimental intervention, were the groups treated equally?
Have the authors taken account of the potential confounding factors in the design
and/or in their analysis? They did not account for the use of positive end
expiratory pressure (PEEP) by the anesthesia provider, also they allowed the
30% O2 group to receive more then 30% O2 when a patients O2 saturation
fell below 95%.
How large was the treatment effect?
How precise was the estimate of the treatment effect?
Do you believe the results? The lack of randomization and evaluation of SSI
via chart review by staff does not give me confidence that I can trust these
findings.
Can the results be applied to the local population?
Do the results of this study fit with other available
evidence? No, this is in opposition to most other studies. A study by this same
group done a couple of years earlier resulted in contradicting findings

X

X

X

X
X
X
X
X
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Table D-1. Cross Study Analysis
Study
Greif et al.
(2000)

Treatment
250 patients received 80% O2
intraoperative;
250 patients received 30% O2
intraoperative

SSI rates
13 (5.2%) in the 80% O2 group
developed SSI;
28 (11.2%) in the 30% O2
group developed SSI.

Morality
1 patient (0.4%) died within the 15 days after
surgery in the 80% O2;
6 patients (2.4%) died within the 15 days after
surgery in the 30 % O2.

Pryor et al.
(2004)

80 patients received 80% O2
intraoperative;
80 patients received 35% O2
intraoperative

20 (25%) in the 80% O2 group
developed SSI;
9 (11.3%) in the 35% O2 group
developed SSI.

Mortality was not measured.

Belda et al.
(2005)

148 patients received 80% O2
intraoperative;
143 patients received 30% O2
intraoperative.

22 (14.9%) in the 80% O2
group developed SSI;
35 (24.4%) in the 30% O2
group developed SSI.

0 patients in the 80% O2 group died;
2 patients in the 35% O2 group died.

Meyhoff et
al. (2009)

685 patients received 80% O2
intraoperative;
701 patients received 30% O2
intraoperative

131 (19.1%) in the 80% O2
group developed SSI;
141 (20.1%) in the 30% O2
group developed SSI.

30 (4.4%) in the 80% O2 group died before the
30-day follow up period;
20 patients (2.9%) in the 30% O2 group died
before the 30-day follow up period.

Bickel et al.
(2011)

107 patients received 80% O2
intraoperative;
103 patients received 30% O2
intraoperative
.

6 (5.6%) in the 80% O2 group
developed SSI;
14 (13.6%) in the 30% O2
group developed SSI

Mortality was not measured.
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Kurz et al.
(2018)

2896 patients received 80% O2
intraoperative;
2853 patients received 30% O2
intraoperative.

118 (4.1%) patients in the 80%
O2 group developed SSI;
112 (3.9%) patients of the 30%
O2 group developed SSI.

20 patients (0.7%) died within the 30 days after
surgery in the 80% O2;
10 patients (0.4%) died within the 30 days after
surgery in the 30% O2

Note: All data tables discussed in the cross-study analysis are included under Appendices A, B, and C.

